Effects doxazosin serum lipids review clinical data molecular basis altered lipid metabolism goal antihypertensive treatment reduction high blood pressure effective management cholesterol levels risk factors coronary heart disease CHD controlled clinical trials doxazosin antihypertensive efficacy comparable classes antihypertensive agents levels total cholesterol low-density lipoprotein LDL cholesterol triglycerides levels high-density lipoprotein cholesterol Doxazosin development CHD fronts First doxazosin binds alpha receptor-mediated responses Second doxazosin direct indirect effects lipid metabolism LDL receptor activity intracellular LDL synthesis synthesis secretion low-density lipoprotein cholesterol lipoprotein lipase activity Doxazosin platelet aggregation Long-term studies actions reductions morbidity mortality rates CHD First-year results Treatment Mild Hypertension Study TOMHS reductions blood pressure antihypertensive agents lipid changes type antihypertensive treatment favorable doxazosin 